Efficacy of Erenumab for the Treatment of Patients with Episodic Migraine with Depression and/or Anxiety

被引：0
|
作者：
Tepper, Stewart [1 ]
Broessner, Gregor [2 ]
Buse, Dawn [3 ]
Schwedt, Todd [4 ]
Strauss, Erik [5 ]
Zhang, Feng [6 ]
Picard, Hernan [6 ]
Mikol, Daniel [6 ]
机构：
[1] Geisel Sch Med, Lebanon, NH USA
[2] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria
[3] Montefiore Headache Ctr, Bronx, NY USA
[4] Mayo Clin, Phoenix, AZ USA
[5] Arzneimittelforsch Leipzig GmbH, Leipzig, Germany
[6] Amgen Inc, Thousand Oaks, CA USA
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P4.105
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis
    Kitamura, Shigekazu
    Takeshima, Takao
    Yui, Daishi
    Lima, Gabriel Paiva da Silva
    Koukakis, Reija
    Peng, Cheng
    Yoshida, Ryuji
    Numachi, Yotaro
    Hasebe, Miki
    NEUROLOGY AND THERAPY, 2023, 12 (06) : 1993 - 2006
  • [32] EFFICACY OUTCOMES IN RESPONDER AND NON-RESPONDER PATIENTS WITH EPISODIC MIGRAINE TREATED PREVENTIVELY WITH ERENUMAB IN STRIVE
    Broessner, G.
    Reuter, U.
    Bonner, J. H.
    Dodick, D. W.
    Picard, H.
    Wen, S.
    Ritter, S.
    Klatt, J.
    Mikol, D. D.
    CEPHALALGIA, 2018, 38 : 55 - 57
  • [33] Evaluation of the effect of erenumab on migraine-specific questionnaire in patients with chronic and episodic migraine
    Chen, Po-Wei
    Karlsson, Mats O.
    Ueckert, Sebastian
    Pritchard-Bell, Ari
    Hsu, Cheng-Pang
    Dutta, Sandeep
    Ahamadi, Malidi
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2023, 12 (12): : 1988 - 2000
  • [34] Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine
    Bekir Enes Demiryurek
    Devrimsel Harika Ertem
    Atilla Tekin
    Mustafa Ceylan
    Yesim Guzey Aras
    Belma Dogan Gungen
    Neurological Sciences, 2016, 37 : 1779 - 1784
  • [35] Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine
    Demiryurek, Bekir Enes
    Ertem, Devrimsel Harika
    Tekin, Atilla
    Ceylan, Mustafa
    Aras, Yesim Guzey
    Gungen, Belma Dogan
    NEUROLOGICAL SCIENCES, 2016, 37 (11) : 1779 - 1784
  • [36] Exposure-Response of Erenumab (AMG 334) in Episodic Migraine Patients
    Vu, Thuy
    Kuchimanchi, Mita
    Wu, Liviawati
    Clements, John D.
    Kahn, Joseph
    Mikol, Daniel
    Lee, Edward
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S81 - S81
  • [37] Efficacy of onabotulinumtoxinA treatment in episodic migraine
    Al-Hashel, Jasem
    Alroughani, Raed
    Almojel, Malak
    Ahmed, Samar Farouk
    FRONTIERS IN NEUROLOGY, 2025, 15
  • [38] Efficacy and Safety of Erenumab in Patients with Episodic Migraine in East Asia: Taiwan and Korea subpopulation analysis of the EMPOwER study
    Wang, S. J.
    Kim, B. K.
    Lima, G. Paiva Da Silva
    Pandhi, S.
    Wen, S.
    Mondal, S.
    Hours-Zesiger, P.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 115 - 116
  • [39] One-year sustained efficacy of erenumab in episodic migraine Results of the STRIVE study
    Goadsby, Peter J.
    Reuter, Uwe
    Hallstroem, Yngve
    Broessner, Gregor
    Bonner, Jo H.
    Zhang, Feng
    Wright, Ian K.
    Chou, Denise E.
    Klatt, Jan
    Picard, Hernan
    Lenz, Robert A.
    Mikol, Daniel D.
    NEUROLOGY, 2020, 95 (05) : E469 - E479
  • [40] Efficacy and safety of erenumab in patients with episodic migraine in East Asia: Taiwan and Korea subpopulation analysis of the EMPOwER study
    Wang, S.
    Kim, Kun B.
    Lima, da Silva G. P.
    Pandhi, S.
    Wen, S.
    Mondal, S.
    Hours-Zesiger, P.
    HEADACHE, 2021, 61 : 124 - 124
12345